Trump Nominates Pro-Life Doctor to be Next FDA Chief

The nomination comes as the FDA is currently conducting a much-anticipated safety review of the abortion drug mifepristone.

Oregon’s Democratic Senators Push for ‘Right to IVF’ – Pro-Life Advocates Raise Concerns

Portland Archbishop Alexander Sample is among many pro-life advocates who have spoken out strongly against similar efforts, blasting IVF for creating ‘hundreds of thousands or even millions of preborn children’ that are often ‘discarded and killed (often in a selective, eugenic manner).’

Federal Funding to Planned Parenthood Resumes As Pro-Life Leaders Continue Urging Congress to Act

Pro-life leaders are calling on Congress to use the means still at their disposal to implement a permanent freeze.

Pro-Life Leaders Urge Congress to Renew Defunding of Planned Parenthood Before July 4

The abortion business is set to regain federal funding on July 4, 2026, unless Congress acts to extend the defunding by another year or permanently block Planned Parenthood from receiving Medicaid dollars.

Report: FDA’s Mifepristone Safety Review Could Be Completed by September

The news comes after the agency earlier this month confirmed that its review was moving into a new data analysis phase.

Tagged abortion drugsabortion pillschemical abortionFDAHHS Kyle Diamantasmifepristonemifepristone reviewmisoprostolTrump administrationU.S. Department of Health and Human ServicesU.S. Food and Drug Administration